The Impact of Thyroid Hormones on Cardiometabolic Risk in Children and Adolescents with Obesity, Overweight and Normal Body Mass Index (BMI): A One-Year Intervention Study

• Published in: Nutrients Vol. 16; no. 16; p. 2650
• Main Authors: Ramouzi, Eleni, Sveroni, Konstantina, Manou, Maria, Papagiannopoulos, Christos, Genitsaridi, Sofia-Maria, Tragomalou, Athanasia, Vourdoumpa, Aikaterini, Koutaki, Diamanto, Paltoglou, George, Kassari, Penio, Charmandari, Evangelia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 11.08.2024; MDPI
• Subjects: Adolescent; Body Mass Index; Cardiometabolic Risk Factors; Cardiovascular Diseases - blood; Cardiovascular Diseases - etiology; Child; Child, Preschool; Chronic illnesses; Female; Hormones; Humans; Insulin resistance; Life Style; Male; Obesity; Overweight - blood; Overweight - therapy; Pediatric Obesity - blood; Pediatric Obesity - therapy; Prospective Studies; thyroid function; thyroid hormone; Thyroid Hormones - blood; Thyrotropin - blood; Uric Acid - blood; Greece; Germany; cardiometabolic risk factors; thyroid function; thyroid hormone; obesity
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu16162650

Thyroid hormones regulate metabolism and have a major impact in maintaining cardiovascular homeostasis. The purpose of our study was to examine the relation of thyrotropin (TSH) and thyroid hormones with cardiometabolic parameters in children and adolescents with obesity, overweight, and normal body mass index (BMI) before and after the implementation of a comprehensive, multidisciplinary, personalized, lifestyle intervention program for 1 year. One thousand three hundred and eleven (n = 1311) children and adolescents aged 2 to 18 years (mean age ± SD: 10.10 ± 2.92 years) were studied prospectively. Patients were categorized as having obesity (n = 727, 55.45%), overweight (n = 384, 29.29%) or normal BMI (n = 200, 15.26%) according to the International Obesity Task Force (IOTF) cutoff points. All patients received personalized guidance on diet, sleep, and physical activity at regular intervals throughout the 1-year period. Detailed clinical evaluation and hematologic, biochemical and endocrinologic investigations were performed at the beginning and the end of the study. Subjects with obesity had a more adverse cardiometabolic risk profile than subjects with overweight and normal BMI on both assessments. At initial evaluation, total T3 concentrations were positively associated with uric acid and HbA1C, and free T4 concentrations were negatively associated with insulin concentrations, while there was no association between TSH concentrations and cardiometabolic risk parameters. Following the 1 year of the multidisciplinary, lifestyle intervention program, the concentrations of lipids, HbA1C, ALT, and γGT improved significantly in all subjects. Changes in TSH concentrations were positively associated with changes in systolic blood pressure (SBP), glucose, triglycerides, and cholesterol concentrations. Changes in free T4 concentrations were negatively associated with changes in cholesterol and insulin concentrations. Furthermore, changes in T3 concentrations were positively associated with changes in HbA1C, glucose, uric acid, and triglyceride concentrations. These findings indicate that in children and adolescents with overweight and obesity, thyroid hormones are associated with indices conferring cardiometabolic risk.